UB Paderborn / Katalog / Suche / in CDI

The European Genome-phenome Archive in 2021

Nucleic acids research, 2022-01, Vol.50 (D1), p.D980

2022

Volltextzugriff (PDF)

The Hill equation and the origin of quantitative pharmacology

Archive for history of exact sciences, 2012-07, Vol.66 (4), p.427-438

2012

Volltextzugriff (PDF)

The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor

Frontiers in pharmacology, 2024-05, Vol.15, p.1375955-1375955

2024

Volltextzugriff (PDF)

Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome

Molecules (Basel, Switzerland), 2020-01, Vol.25 (2), p.429

2020

Volltextzugriff (PDF)

Cardioprotection by endoplasmic reticulum stress-induced autophagy

Antioxidants & redox signaling, 2011-06, Vol.14 (11), p.2191

2011

Volltextzugriff (PDF)

Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans

Basic research in cardiology, 2021-12, Vol.116 (1), p.24, Article 24

2021

Volltextzugriff (PDF)

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

Free radical biology & medicine, 2007-09, Vol.43 (5), p.720-729

2007

Volltextzugriff (PDF)

Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction

International journal of molecular sciences, 2023-09, Vol.24 (17), p.13253

2023

Volltextzugriff (PDF)

BGP-15 Inhibits Hyperglycemia-Aggravated VSMC Calcification Induced by High Phosphate

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9263

2021

Volltextzugriff (PDF)

The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications

International journal of molecular sciences, 2022-12, Vol.24 (1), p.446

2022

Volltextzugriff (PDF)

The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy

Molecules (Basel, Switzerland), 2019-02, Vol.24 (3), p.586

2019

Volltextzugriff (PDF)

A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9831

2021

Volltextzugriff (PDF)

Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2882

2018

Volltextzugriff (PDF)

The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium

Frontiers in pharmacology, 2022-12, Vol.13, p.1043275-1043275

2022

Volltextzugriff (PDF)

Efficacy of Pre- and Post-Treatment by Topical Formulations Containing Dissolved and Suspended Silybum marianum against UVB-Induced Oxidative Stress in Guinea Pig and on HaCaT Keratinocytes

Molecules (Basel, Switzerland), 2016-09, Vol.21 (10), p.1269-1269

2016

Volltextzugriff (PDF)

Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2124

2020

Volltextzugriff (PDF)

Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome

International journal of molecular sciences, 2018-03, Vol.19 (3), p.798

2018

Volltextzugriff (PDF)

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy

Journal of translational medicine, 2019-07, Vol.17 (1), p.229-16, Article 229

2019

Volltextzugriff (PDF)

Exercise-mitigated sex-based differences in aging: from genetic alterations to heart performance

American journal of physiology. Heart and circulatory physiology, 2021-02, Vol.320 (2), p.H854-H866

2021

Volltextzugriff (PDF)

Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment

Frontiers in pharmacology, 2021-04, Vol.12, p.650207-650207

2021

Volltextzugriff (PDF)

Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: Extended Mitochondrial Longevity

Pharmaceutics, 2022-01, Vol.14 (2), p.226

2022

Volltextzugriff (PDF)

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

Journal of molecular and cellular cardiology, 2007-03, Vol.42 (3), p.508-516

2007

Volltextzugriff (PDF)

An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A1 Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium

Molecules (Basel, Switzerland), 2019-06, Vol.24 (12), p.2207

2019

Volltextzugriff (PDF)

Changes of Hematological and Hemorheological Parameters in Rabbits with Hypercholesterolemia

Metabolites, 2021-04, Vol.11 (4), p.249

2021

Volltextzugriff (PDF)

Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (3), p.359

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The European Genome-phenome Archive in 2021

The Hill equation and the origin of quantitative pharmacology

The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor

Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome

Cardioprotection by endoplasmic reticulum stress-induced autophagy

Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction

BGP-15 Inhibits Hyperglycemia-Aggravated VSMC Calcification Induced by High Phosphate

The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications

The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy

A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far

Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease

The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium

Efficacy of Pre- and Post-Treatment by Topical Formulations Containing Dissolved and Suspended Silybum marianum against UVB-Induced Oxidative Stress in Guinea Pig and on HaCaT Keratinocytes

Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone

Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy

Exercise-mitigated sex-based differences in aging: from genetic alterations to heart performance

Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment

Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: Extended Mitochondrial Longevity

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A1 Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium

Changes of Hematological and Hemorheological Parameters in Rabbits with Hypercholesterolemia

Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats

Suchergebnisse filtern